Cryogenic OGS
Cryogenic OGS (CRYOGENIC) share price was ₹374.30 at the 28 Oct 2026 close; market capitalisation ₹535 Cr; sector Capital Goods. The share price rose 75.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹20 Cr, against ₹19 Cr a year earlier and net profit was ₹4 Cr, against ₹3 Cr a year earlier (compared with Mar 2025). Promoters held 74.29% of Cryogenic OGS in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 55/100 (Good) as of 28 Oct 2026.
Key Fundamentals
SMEIndustrial ManufacturingCapital GoodsPrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Industrials › Capital Goods › Industrial Products
| ₹3,937.70 | 97.06 | 46,583 Cr | 14.30 | 0.04% | 19.61% | 25.98% | 4,896 Cr | 477 Cr | |
| ₹1,646.80 | 86.22 | 31,755 Cr | 11.09 | 0.10% | 11.28% | 14.83% | 5,510 Cr | 401 Cr | |
| ₹30,140.00 | 48.35 | 26,648 Cr | 5.71 | 0.35% | 11.76% | 15.68% | 4,959 Cr | 552 Cr | |
| ₹956.40 | 67.64 | 21,751 Cr | 10.87 | 0.00% | 16.79% | 22.04% | 2,236 Cr | 323 Cr | |
| ₹3,202.20 | 62.09 | 21,466 Cr | 4.53 | 0.00% | 7.64% | 12.03% | 4,043 Cr | 345 Cr | |
| ₹16,520.00 | 100.97 | 17,648 Cr | 5.81 | 0.21% | 4.56% | 5.85% | 3,824 Cr | 176 Cr | |
| — | — | 535 Cr | 9.78 | 0.00% | 18.63% | 21.52% | — | — | |
| Median 7 companies | ₹3,569.95 | 76.93 | 21,751 Cr | 9.78 | 0.04% | 11.76% | 15.68% | 4,470 Cr | 373 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 84/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Debtor days have improved from 65.6 to 42.9 days.
- Promoter holding has increased by 0.77% over last quarter.
Weaknesses
2- Stock is trading at 10.9 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 29% · Mar 2026
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 13 | 19 | 21 | 20 |
| Expenses | 10 | 15 | 15 | 14 |
| Operating Profit | 4 | 4 | 6 | 6 |
| OPM % | 27% | 22% | 27% | 29% |
| Other Income | 0 | 0 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| PBT | 4 | 5 | 7 | 6 |
| Tax % | 26% | 27% | 24% | 28% |
| Net Profit | 3 | 3 | 6 | 4 |
| EPS (₹) | 2.65 | 3.15 | 3.87 | 3.13 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 23 | 22 | 24 | 33 | 41 |
| Expenses | 19 | 16 | 18 | 25 | 29 |
| Operating Profit | 4 | 6 | 6 | 8 | 11 |
| OPM % | 19% | 26% | 26% | 24% | 28% |
| Other Income | 1 | 1 | 1 | 1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 |
| PBT | 4 | 5 | 7 | 8 | 13 |
| Tax % | 26% | 26% | 25% | 26% | 25% |
| Net Profit | 3 | 4 | 5 | 6 | 10 |
| EPS (₹) | 3.12 | 3.89 | 5.1 | 5.8 | 7.13 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.5 | 0.5 | 0.5 | 10 | 14 |
| Reserves | 13 | 17 | 22 | 18 | 40 |
| Borrowings | 2 | 0 | 0 | 0 | 0 |
| Other Liabilities | 7 | 6 | 5 | 5 | 12 |
| Total Liabilities | 22 | 24 | 28 | 34 | 67 |
| Fixed Assets | 8 | 7 | 7 | 7 | 16 |
| CWIP | 0 | 0 | 0 | 0 | 2 |
| Investments | 1 | 1 | 2 | 2 | 2 |
| Other Assets | 14 | 15 | 19 | 25 | 47 |
| Total Assets | 22 | 24 | 28 | 34 | 67 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 2 | 2 | 2 | 2 | 8 |
| Investing | -1 | 0 | -1 | -1 | -21 |
| Financing | -1 | -2 | 0 | 0 | 15 |
| Net Cash Flow | 1 | 0 | 0 | 1 | 3 |
| Free Cash Flow | 1 | 1 | 2 | 2 | 6 |
| CFO/EBITDA | 88 | 53 | 52 | 53 | 101 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 41 | 85 | 80 | 73 | 43 |
| Inventory Days | 59 | 58 | 106 | 112 | 138 |
| Days Payable | 161 | 162 | 116 | 57 | 44 |
| Cash Conversion Cycle | -60 | -19 | 71 | 128 | 138 |
| Working Capital Days | -51 | 15 | 62 | 95 | 91 |
| ROCE % | — | 33% | 34% | 32% | 30% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cryogenic OGS insights
49 extracted metrics + investor summaries across FY22–FY26.
Documents
Frequently Asked Questions about Cryogenic OGS
What does Cryogenic OGS Ltd do?
Where is Cryogenic OGS Ltd (CRYOGENIC) listed?
Which sector does Cryogenic OGS Ltd belong to?
What is the market capitalisation of Cryogenic OGS Ltd?
What is the 52-week high and low of Cryogenic OGS Ltd?
What is the Return on Equity (ROE) of Cryogenic OGS Ltd?
Company Information
Incorporated in 1997, Cryogenic OGS Ltd provides equipment solutions for Metering, Filtering, Pressure Reduction, Dosing, and Blending.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544440.md for Cryogenic OGS Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.